Jiaran Shi
Impact in
-
- COVID-19 Clinical Research Studies
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
-
- Atrial Fibrillation Management and Outcomes 3
- Cardiac Valve Diseases and Treatments 2
- Co-authors
- Xingxiang Wang (10 shared papers)Kun Yang (10 shared papers)Yanan Chu (3 shared papers)Jinxiu Yang (3 shared papers)Pingping Zhang (1 shared paper)Xiaosheng Hu (4 shared papers)Rifeng Gao (9 shared papers)Zhujun Hu (1 shared paper)
In The Last Decade
Jiaran Shi
25 papers receiving 346 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 59
- Cardiology and Cardiovascular Medicine 61
- Cancer Research 38
- Immunology 45
- Molecular Biology 113
Countries citing papers authored by Jiaran Shi
This map shows the geographic impact of Jiaran Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaran Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaran Shi more than expected).
Fields of papers citing papers by Jiaran Shi
This network shows the impact of papers produced by Jiaran Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaran Shi. The network helps show where Jiaran Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaran Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 99 | |
| 2 | 2024 | 56 | |
| 3 | 2019 | 36 | |
| 4 | 2023 | 35 | |
| 5 | 2020 | 16 | |
| 6 | 2024 | 14 | |
| 7 | 2021 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2025 | 3 |
About Jiaran Shi
Jiaran Shi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Infectious Diseases and Neurology, having authored 28 papers that have together received 354 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cardiac Structural Anomalies and Repair (2 papers), Cardiac Valve Diseases and Treatments (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (59 citations), Cardiology and Cardiovascular Medicine (61 citations), Cancer Research (38 citations), Immunology (45 citations) and Molecular Biology (113 citations). Jiaran Shi has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Xingxiang Wang, Kun Yang, Yanan Chu, Jinxiu Yang, Pingping Zhang, Xiaosheng Hu, Rifeng Gao, Zhujun Hu, Junbo Ge and Kai Hu. Their work appears in journals such as Aging, Translational research, Reviews in Cardiovascular Medicine, Nature Communications and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.